£77.64

Springer Interferon Alpha-2: Pre-Clinical and Clinical Evaluation: Proceedings of the Symposium held in Adjunction with the Second International Conference on ... 13, 1984: 27 (Developments in Oncology, 27)

Price data last checked 114 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

About as cheap as it gets. The only time it was cheaper was 1 year ago.

£78 today · all-time low £74 (Sep 2024) · usually the usual

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 617 days • 617 data points (No recent data available)

Historical
Generating forecast...
£79.75 £73.73 £75.05 £76.36 £77.67 £78.98 £80.30 10 June 2024 11 November 2024 14 April 2025 15 September 2025 16 February 2026

Price Distribution

Price distribution over 617 days • 4 price levels

Days at Price
Current Price
26 days 419 days 23 days · current 149 days 0 105 210 314 419 £74 £75 £78 £80 Days at Price

Price Analysis

Most common price: £75 (419 days, 67.9%)

Price range: £74 - £80

Price levels: 4 different prices over 617 days

Description

Interferon alpha-2 is a genetically engineered, highly purified pharmaceutical agent that has undergone extensive phase I and phase II clinical study in more than 1000 patients. The material has biological activity by intravenous, intramus cular and subcutaneous routes. Clinical toxicity principally involves the 'influen za like' syndrome previously seen with native interferons. Other important toxi cities include anorexia, hepatitis, confusion and myelosuppression. Tolerable doses in multiple schedules and routes of administration have been determined. Phase II clinical trials with multiple routes and schedules of administration have been performed. Significant clinical activity has been found in non Hodgkin's lymphomas (both low grade and high grade), refractory and relapsing multiple myeloma, hairy cell leukemia, Kaposi's sarcoma, with suggestions of activity in Hodgkin's disease, renal cell carcinoma, and melanoma. The studies performed to date have for the most part involved small numbers of heavily pre-treated patients. Large-scale clinical trials in some of these disea ses are now warranted in populations of patients with as little bulk disease and prior treatment as is feasible for each tumour type. This is particularly the case in . Hodgkin's disease and subcategories of the non-Hodgkin's lymphomas. Alterna tely, interferon alpha-2 might be used to maintain remissions induced by other modalities (i. e. , in NHL, multiple myeloma, ovarian cancer). In some advanced disease settings, combinations of interferon alpha-2 with chemotherapeutic agents should now be investigated.

Product Specifications

Format
paperback
Domain
Amazon UK
Publication Date
05 October 2011
Listed Since
21 December 2012

Barcode

No barcode data available

Similar Products You Might Like

Interferon Alpha-2: Pre-Clinical and Clinical Evaluation: Proceedings of the Symposium held in Adjunction with the Second International Conference on ... 13, 1984: 27 (Developments in Oncology, 27)
99% match

Interferon Alpha-2: Pre-Clinical and Clinical Evaluation: Proceedings of the Symposium held in Adjunction with the Second International Conference on ... 13, 1984: 27 (Developments in Oncology, 27)

Springer

£84.43 18 Mar 2026
Interferon and Cancer
96% match

Interferon and Cancer

Springer

£73.75 02 Apr 2026
Interferon: The Science and Selling of a Miracle Drug (Routledge Studies in the History of Science, Technology and Medicine)
96% match

Interferon: The Science and Selling of a Miracle Drug (Routledge Studies in the History of Science, Technology and Medicine)

Routledge

£131.92 27 Jan 2026
Immune Interferon: Properties and Clinical Applications (Pharmacology and Toxicology: Basic and Clinical Aspects)
96% match

Immune Interferon: Properties and Clinical Applications (Pharmacology and Toxicology: Basic and Clinical Aspects)

CRC Press

£239.20 28 Jan 2026
Anti-Infective Applications of Interferon-Gamma
95% match

Anti-Infective Applications of Interferon-Gamma

CRC Press

£140.36 25 Jan 2026
Interferons: Characterization and Clinical Applications Book
95% match

Interferons: Characterization and Clinical Applications Book

Nova Science Publishers Inc

£142.99 19 Apr 2026
Viruses and Interferon: Current Research
95% match

Viruses and Interferon: Current Research

Caister Academic Press Limited

£199.00 10 Mar 2026
Infections Related to Biologics, An Issue of Infectious Disease Clinics of North America: Volume 34-2 (The Clinics: Internal Medicine, Volume 34-2)
95% match

Infections Related to Biologics, An Issue of Infectious Disease Clinics of North America: Volume 34-2 (The Clinics: Internal Medicine, Volume 34-2)

Elsevier

£68.52 08 Mar 2026
Cancer Immunology: Innovative Approaches to Therapy: 27 (Cancer Treatment and Research, 27)
95% match

Cancer Immunology: Innovative Approaches to Therapy: 27 (Cancer Treatment and Research, 27)

Springer

£146.40 24 Feb 2026
Cancer Immunology: Innovative Approaches to Therapy: 27 (Cancer Treatment and Research, 27)
95% match

Cancer Immunology: Innovative Approaches to Therapy: 27 (Cancer Treatment and Research, 27)

Springer

£176.00 09 Apr 2026
Bacterial Activation of Type I Interferons
95% match

Bacterial Activation of Type I Interferons

Springer

£74.58 02 Apr 2026
Springer - Novel Immunotherapeutic Approaches to Cancer Treatment
95% match

Springer - Novel Immunotherapeutic Approaches to Cancer Treatment

Springer

£108.91 20 Apr 2026
Springer - Novel Immunotherapeutic Approaches to Cancer Treatment
95% match

Springer - Novel Immunotherapeutic Approaches to Cancer Treatment

Springer

£113.48 18 Apr 2026
Immune Mediators in Cancer: Methods and Protocols: 2108 (Methods in Molecular Biology, 2108)
95% match

Immune Mediators in Cancer: Methods and Protocols: 2108 (Methods in Molecular Biology, 2108)

Humana

£92.38 23 Feb 2026
Infection and Cancer: Bi-Directorial Interactions
94% match

Infection and Cancer: Bi-Directorial Interactions

Springer

£109.24 07 Mar 2026
Burkitt Lymphoma: Updates in Etiology, Symptoms, Molecular Genetics and Treatment Options
94% match

Burkitt Lymphoma: Updates in Etiology, Symptoms, Molecular Genetics and Treatment Options

£192.99 28 Feb 2026
Malignant Lymphomas and Hodgkin’s Disease: Experimental and Therapeutic Advances: Proceedings of the Second International Conference on Malignant ... – 16, 1984: 32 (Developments in Oncology, 32)
94% match

Malignant Lymphomas and Hodgkin’s Disease: Experimental and Therapeutic Advances: Proceedings of the Second International Conference on Malignant ... – 16, 1984: 32 (Developments in Oncology, 32)

Springer

£291.99 11 Jan 2026
Malignant Lymphomas and Hodgkin’s Disease: Experimental and Therapeutic Advances: Proceedings of the Second International Conference on Malignant ... – 16, 1984: 32 (Developments in Oncology, 32)
94% match

Malignant Lymphomas and Hodgkin’s Disease: Experimental and Therapeutic Advances: Proceedings of the Second International Conference on Malignant ... – 16, 1984: 32 (Developments in Oncology, 32)

Springer

£398.50 13 Jan 2026
OSH Infection in the Immunocompromised Host (Oxford Specialist Handbooks)
94% match

OSH Infection in the Immunocompromised Host (Oxford Specialist Handbooks)

Oxford University Press

£52.88 28 Feb 2026
Tumor Immunology: Methods and Protocols: 1393 (Methods in Molecular Biology, 1393)
94% match

Tumor Immunology: Methods and Protocols: 1393 (Methods in Molecular Biology, 1393)

Humana

£68.79 06 Mar 2026
Negative Co-Receptors and Ligands: 350 (Current Topics in Microbiology and Immunology, 350)
94% match

Negative Co-Receptors and Ligands: 350 (Current Topics in Microbiology and Immunology, 350)

Springer

£96.02 09 Mar 2026
RNA Tumor Viruses, Oncogenes, Human Cancer and AIDS: On the Frontiers of Understanding: Proceedings of the International Conference on RNA Tumor ... 1984: 28 (Developments in Oncology, 28)
94% match

RNA Tumor Viruses, Oncogenes, Human Cancer and AIDS: On the Frontiers of Understanding: Proceedings of the International Conference on RNA Tumor ... 1984: 28 (Developments in Oncology, 28)

Springer

£164.62 27 Jan 2026
RNA Tumor Viruses, Oncogenes, Human Cancer and AIDS: On the Frontiers of Understanding: Proceedings of the International Conference on RNA Tumor ... 1984: 28 (Developments in Oncology, 28)
94% match

RNA Tumor Viruses, Oncogenes, Human Cancer and AIDS: On the Frontiers of Understanding: Proceedings of the International Conference on RNA Tumor ... 1984: 28 (Developments in Oncology, 28)

Springer

£150.04 28 Jan 2026
Academic Press - Multifaceted Role of IL-1 in Cancer and Inflammation
94% match

Academic Press - Multifaceted Role of IL-1 in Cancer and Inflammation

Academic Press

£114.57 18 Apr 2026